The Governance Implications of DOJ’s New Corporate Fraud Enforcement Guidance
- March 15, 2024
- Michael W. Peregrine , McDermott Will & Emery
- Ashley C. Hoff , McDermott Will & Emery LLP
In a series of presentations to the American Bar Association’s 39th National Institute on White Collar Crime in early March, senior Department of Justice (DOJ) leaders provided updates on existing initiatives under its ongoing corporate enforcement program and introduced important new initiatives of that program. Both carry great significance for board oversight of the corporate compliance risks of health care organizations.
ARTICLE TAGS
You must be logged in to access this content.